Company Overview of Ignyta, Inc.
Ignyta, Inc., a biotechnology company, engages in catalyzing personalized medicine in autoimmune diseases. The company discovers, develops, validates, and commercializes diagnostic tests and therapeutic drugs for rheumatoid arthritis (RA) and other autoimmune diseases. It offers Methylome, a computational platform that helps accelerate the discovery of biomarkers for diagnostic and therapeutic purposes. Ignyta, Inc. was formerly known as NexDx, Inc. and changed its name to Ignyta, Inc. in October 2012. The company was founded in 2011 and is based in San Diego, California.
11575 Sorrento Valley Road
San Diego, CA 92121
Founded in 2011
Key Executives for Ignyta, Inc.
Ignyta, Inc. Key Developments
Similar Private Companies By Industry
|HµREL Corporation||United States|
|Principia Pharmaceuticals Corporation||United States|
|Enzium, Inc.||United States|
|Schepens Eye Research Institute Inc.||United States|
|BioValve Technologies, Inc.||United States|
Recent Private Companies Transactions
June 22, 2012
Most Searched Private Companies
|Company Name||Geographic Region|
|NYC2012, Inc.||United States|
|Lawyers Committee for Civil Rights Under Law||United States|
|Rush University||United States|
|Citizens Budget Commission||United States|
Post a JobJobs
- Adelphi, MD | University of Maryland University CollegePosted: May 07
- Cambridge, MA | ElsevierPosted: May 23
- Seattle, WA | Marina Sirras & AssociatesPosted: Apr 09
- San Francisco, CA | Confidential Biotechnology CompanyPosted: May 13
Sponsored Financial Commentaries
To contact Ignyta, Inc., please visit www.nexdx.com. Company data is provided by Capital IQ. Please use this form to report any data issues.